Abstract: A coating for implantable medical devices and a method for fabricating thereof are disclosed. The coating includes a mixture of a hydrophobic polymer and a polymeric hydrophilic additive, wherein the hydrophobic polymer and the hydrophilic additive form a physically entangled or interpenetrating system.

Abstract: A polymer coating for medical devices based on a derivatized poly(ethylene-co-vinyl alcohol) is disclosed. A variety of polymers are described to make coatings for medical devices, particularly, for drug delivery stents. The polymers include poly(ethylene-co-vinyl alcohol) modified by alkylation, esterification, and introduction of fluorinated alkyl fragments, polysiloxane fragments and poly(ethylene glycol) fragments into the macromolecular chains of poly(ethylene-co-vinyl alcohol).

Abstract: This invention is directed to a balloon catheter having at least one advancement wire with a distal end section secured to a distal tip section of the catheter, and with a textured section extending along the outer surface of at least a portion of an inflatable section of the catheter balloon. The textured section of the advancement wire preferably improves the ability of the balloon to remain in position in the patient's body lumen during inflation of the balloon to perform a medical procedure such as balloon angioplasty or stent touch-up.

Abstract: The present invention is directed to a flexible expandable stent for implantation in a body lumen, such as a coronary artery. The stent generally includes a series of metallic cylindrical rings longitudinally aligned on a common axis of the stent and interconnected by a series of links which be polymeric or metallic. Varying configurations and patterns of the links and rings provides longitudinal and flexural flexibility to the stent while maintaining sufficient column strength to space the cylindrical rings along the longitudinal axis and providing a low crimp profile, enhanced stent security and radial stiffness.

Abstract: A method of making a catheter balloon, and a balloon formed thereby, in which a polymeric tube is radially expanded in a mold having a wall with an outer surface and an inner surface defining a chamber, and having at least a section with one or more channels in the wall. The channels result in improved transfer of heat to the polymeric tube within the chamber of the mold during blow molding of the tube to form a balloon, so that the tube is heated more quickly and evenly. One aspect of the invention is directed to a balloon having sections with improved thin walls.

Abstract: A balloon catheter having a balloon with a thickened wall portion extending along at least a portion of the working length section of the balloon in a noninflated configuration. The balloon has a first layer formed of a first polymeric material and a second layer formed of a second, different polymeric material, the second layer having a wall thickness which is greater along the central working length section than the wall thickness of the second layer along a section proximal and/or a section distal to the central working length of the balloon. In a presently preferred embodiment, the first layer is formed of a porous material such as expanded polytetrafluoroethylene (ePTFE), and the second layer of the balloon is formed of an elastomeric polymer. The balloon catheter has a highly flexible distal section and a relatively high strength, low profile balloon, due to the balloon configuration of the invention.

Abstract: This disclosure covers polymers, some of which are useful in medical device applications. Some of these medical devices are implantable within a mammalian body, such as in a body lumen. The copolymers comprise at least one alcoholic moiety derived from a diol, triol, or polyol. Additionally, the copolymers comprise an acidic moiety, derived from a polycarboxylic acid, and a biobeneficial moiety. Some of these copolymers are biodegradable or bioerodable. Medical devices comprising these polymers and methods of making these polymers are within the scope of this disclosure.

Abstract: A polymeric coating for a medical device that comprises poly(lactic acid) and a block copolymer including blocks of poly(ethylene glycol) and poly(butylene terephthalate) is provided.

Abstract: An assembly is provided which can crimp or compress an intraluminal device or measure the radial strength of an intraluminal device. The crimping assembly includes at least two moving-element subassemblies, each with a pair of moving elements. The moving elements having a first side and a second side joining at a tip. The moving-element subassembly is able to move in such a way that the moving elements move relative to each other from a first position with the tips offset from each other by a first distance, to a second position with the tips offset from each other by a second distance different than the first distance. The assembly also includes a movement assembly that interfaces with each of the moving-element subassemblies. The movement assembly moves the pairs of moving elements between the first position and the second position.

Abstract: A capture device for removal of clots and foreign bodies from vasculature or filtering of particulate from blood flow. The parachute-like capture device is connected to an elongate wire located within a longitudinally elongated tubular member. The capture device is radially expandable and is refolded to a reduced profile during contraction.

Abstract: High radiopacity is achieved in a polymeric marker by combining a polymeric resin, a powdered radiopaque agent having uniformly shaped particles of a specific particle size distribution and a wetting agent. The method to produce the marker calls for the blending and pelletization of these materials followed by extrusion onto support beading. The resulting supported tubing is subsequently cut to length with the beading still in place. After ejection of the beading remnant the marker is slipped into place on the device to be marked and attached by melt bonding. Marking of a guidewire allows lesions to be measured while the marking of balloon catheters allow the balloon to be properly positioned relative to a lesion.

Abstract: This disclosure covers polymers, some of which are useful in medical device applications. Some of these medical devices are implantable within a mammalian body, such as in a body lumen. The copolymers comprise at least one alcoholic moiety derived from a diol, triol, or polyol. Additionally, the copolymers comprise an acidic moiety, derived from a polycarboxylic acid, and a biobeneficial moiety. Some of these copolymers are biodegradable or bioerodable. Medical devices comprising these polymers and methods of making these polymers are within the scope of this disclosure.

Abstract: A catheter having an elongated shaft with an inflation lumen and a guidewire lumen, a balloon on a distal shaft section, and a proximal intermediate port proximal to the balloon and a distal intermediate port distal to the balloon, the intermediate ports being in communication with the guidewire lumen and being configured to slidably receive a guidewire therethrough so that the guidewire extends into or out of a proximal section of the guidewire lumen through the proximal intermediate port, extends along an outer surface of the balloon, and extends into or out of a distal section of the guidewire lumen through the distal intermediate port. The balloon is inflated in a patient's blood vessel to perform a medical procedure, with the section of the guidewire extending along an outer surface of the balloon providing improved balloon retention at the desired location in the blood vessel during inflation of the balloon.

Abstract: A method of coating an implantable medical device is disclosed, the method includes applying a composition onto the device and drying the composition at elevated temperature in an environment having increased relative humidity.

Abstract: This invention relates to a method of extending the shelf-life of constructs, in particular bioabsorbable stents, comprising semi-crystalline polymers by increasing the crystallinity of the polymers.

Abstract: Methods for coating different regions of an implantable device are disclosed. An embodiment of the method includes dipping a first portion of the implantable device into a first coating substance, and then centrifuging the implantable device to provide an even coating. Next, a second portion of the implantable device is dipped into a second coating substance, and the implantable device is again centrifuged, resulting in an even second coating. In another embodiment, a first coating substance is applied to an interior surface of a cylindrical implantable device, such as a stent or graft, and a second coating substance is applied to an exterior surface. A centrifuge step is performed so that the first coating substance is preferentially and uniformly applied on the interior surface of the implantable device and the second coating substance is preferentially and uniformly applied on the exterior surface of the implantable device.

Abstract: Methods, devices, kits and compositions to treat a myocardial infarction. In one embodiment, the method includes the prevention of remodeling of the infarct zone of the ventricle using a combination of therapies. The method may include the introduction of structurally reinforcing agents. In other embodiments, agents may be introduced into a ventricle to increase compliance of the ventricle. The prevention of remodeling may include the prevention of thinning of the ventricular infarct zone. Another embodiment includes the reversing or prevention of ventricular remodeling with electro-stimulatory therapy. The unloading of the stressed myocardium over time effects reversal of undesirable ventricular remodeling. These therapies may be combined with structurally reinforcing therapies. In other embodiments, the structurally reinforcing component may be accompanied by other therapeutic agents. These agents may include but are not limited to pro-fibroblastic and angiogenic agents.

Abstract: A coating for a medical device, particularly for a drug eluting stent, is described. The coating includes a polyacetal-based polymer.

Abstract: This invention comprises guidewires, stents and other intraluminal devices having a performance enhancing coating deposited using physical vapor deposition (PVD) or chemical vapor deposition (CVD). Preferably, a radiopaque coating comprising platinum, tungsten, iridium, tantalum or the like is deposited on a desired portion of the device. Alternatively, the performance enhancing coating is a wear resistant coating of carbides such as tungsten carbide, titanium carbide, or nitrides such as titanium nitride.

Abstract: Patterns for polymeric radially expandable implantable medical devices such as stents for implantation into a bodily lumen are disclosed. Some patterns comprise radially expandable cylindrical rings that are longitudinally aligned, each ring comprising diamond-shaped elements, each formed by four linear bar arms. The patterns con also comprise a cross-like element comprising four linear bar arms interconnected within the diamond-shaped elements, and at least one link between adjacent rings. In other patterns, the rings comprise peaks and valleys formed by linear bar arms. wherein pairs of rings are configured such that the peaks of one pair are connected to the valleys of the other pair at apices of the peaks and valleys to form diamond shaped regions. In yet other patterns, there are two v-shaped elements formed by two short bar arms within the diamond-shaped elements, and a connecting bar arm connecting the two v-shaped elements.